Coherent's SiC Announcement Fuels Optimism, But Core Thesis Demands Hard Data

What happened

Coherent Corp's stock jumped 9% on April 10, 2026, after unveiling advances in silicon carbide epitaxy technology, which the company tied to powering AI data centers and industrial systems. The DeepValue report emphasizes that Coherent's investment case hinges on observable growth in its Datacenter & Communications segment, driven by InP manufacturing and NVIDIA's $2B funding for capacity expansion. This SiC breakthrough, while potentially complementary, does not directly address the report's critical metrics: Datacenter profit sustainability, inventory discipline, or disclosed capex tied to InP ramp-ups. Management has yet to provide evidence that the NVIDIA investment is accelerating operational build-out, a key risk highlighted in filings. Thus, the rally reflects sentiment around AI narratives rather than substantive progress on the execution-dependent thesis.

Implication

The stock's surge underscores market enthusiasm for AI-linked news, but without operational proof, it risks reversal if upcoming reports show stagnation in Datacenter profit or inventory builds. Coherent must still demonstrate that Datacenter & Communications segment profit can hold or grow while inventories are controlled, as per the report's thesis breakers. SiC technology may expand industrial opportunities, but the primary value driver remains AI datacenter optics, where InP and co-packaged optics are critical for sustaining high valuations. Elevated multiples (P/E 143.9) offer no margin of safety, making any roadmap slippage or collaboration re-scope a severe downside catalyst. Prudent investors should monitor next-quarter disclosures for evidence of execution rather than reacting to promotional updates that don't alter fundamental risks.

Thesis delta

The SiC announcement does not shift the core investment thesis, which remains dependent on Datacenter & Communications execution and NVIDIA collaboration outcomes. This development is incremental and peripheral, failing to address the need for observable evidence in profit dollars, inventory management, or capex timing. Investors should maintain the 'WAIT' rating until operational proofs emerge, as the thesis unchangedly requires tangible progress beyond narrative-driven optimism.